Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia

被引：9

作者：

Hara, Takeshi ^{[1
]}

Matsumoto, Takuro ^{[1
]}

Shibata, Yuhei ^{[1
]}

Nakamura, Nobuhiko ^{[1
]}

Nakamura, Hiroshi ^{[1
]}

Ninomiya, Soranobu ^{[1
]}

Kitagawa, Junichi ^{[1
]}

Nannya, Yasuhito ^{[1
]}

Shimizu, Masahito ^{[1
]}

Ito, Hiroyasu ^{[2
]}

Saito, Kuniaki ^{[3
,4
]}

Tsurumi, Hisashi ^{[1
]}

机构：

[1] Gifu Univ, Dept Internal Med 1, Grad Sch Med, 1-1 Yanagido, Gifu, Gifu 5011194, Japan

[2] Gifu Univ, Dept Informat Clin Med, Grad Sch Med, Gifu, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan

[4] Kyoto Univ, Fac Med, Kyoto, Japan

来源：

LEUKEMIA & LYMPHOMA | 2016年 / 57卷 / 09期

关键词：

B-CELL LYMPHOMA; CYTOGENETICS; AML;

D O I：

10.3109/10428194.2015.1128541

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2208 / 2211

页数：4

共 50 条

[21] QUANTITATIVE ASSESSMENT OF INDOLEAMINE 2,3-DIOXYGENASE(IDO) EXPRESSION PREDICTS CLINICAL OUTCOME IN ACUTE MYELOID LEUKEMIA PATIENTS AT DIAGNOSIS
Parisi, S.
Ragaini, S.
Ocadlikova, D.
Lecciso, M.
Paolini, S.
Papayannidis, C.
Abbenante, M.
Sartor, C.
Marconi, G.
Ottaviani, E.
Cavo, M.
Curti, A.
HAEMATOLOGICA, 2018, 103 : S72 - S72
[22] EXPRESSION AND PROGNOSTIC IMPACT OF INDOLEAMINE 2,3-DIOXYGENASE IN HODGKIN'S LYMPHOMA
Kryachok, I.
Novosad, O.
Skrypets, T.
Ulianchenko, K.
Tytorenko, I.
Khranovska, N.
Skachkova, O.
Svergun, N.
Gorbach, O.
HAEMATOLOGICA, 2016, 101 : 10 - 11
[23] Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients
Munipally, Praveen Kumar
Agraharm, Satish G.
Valavala, Vijay Kumar
Gundae, Sridhar
Turlapati, Naga Raju
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2011, 117 (05) : 254 - 258
[24] High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Chamuleau, Martine E. D.
Van de Loosdrecht, Arjan A.
Hess, Corine J.
Janssen, Jeroen J. W. M.
Zevenbergen, Adri
Delwel, Ruud
Valk, Peter J. M.
Lowenberg, Bob
Ossenkoppele, Geri J.
BLOOD, 2007, 110 (11) : 142B - 142B
[25] Indoleamine 2,3-dioxygenase expression and serum kynurenine concentrations in patients with diffuse large B-cell lymphoma
Ninomiya, Soranobu
Hara, Takeshi
Tsurumi, Hisashi
Goto, Naoe
Saito, Kuniaki
Seishima, Mitsuru
Takami, Tsuyoshi
Moriwaki, Hisataka
LEUKEMIA & LYMPHOMA, 2012, 53 (06) : 1143 - 1145
[26] Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
Lindstrom, Vesa
Aittoniemi, Janne
Jylhava, Juulia
Eklund, Carita
Hurme, Mikko
Paavonen, Timo
Oja, Simo S.
Itala-Remes, Maija
Sinisalo, Marjatta
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (05): : 363 - 365
[27] High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Chamuleau, Martine E. D.
de Loosdrecht, Arjan A. van
Hess, Corine J.
Janssen, Jeroen I. W. M.
Zevenbergen, Adri
Delwel, Ruud
Valk, Peter J. M.
Loewenberg, Bob
Ossenkoppele, Gert J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1894 - 1898
[28] HIGH INDO (INDOLEAMINE 2,3-DIOXYGENASE) MRNA LEVEL IN BLASTS OF ACUTE MYELOID LEUKEMIC PATIENTS PREDICTS POOR CLINICAL OUTCOME
Chamuleau, M. E. D.
de Loosdrecht, A. A. van
Hess, C. J.
Zevenbergen, A.
Janssen, J. W. M.
Delwel, R.
Valk, P. J. M.
Lowenberg, B.
Ossenkoppele, G. J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 8 - 8
[29] Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia
Yu Yao
Yu-ying Liu
Jian-feng Li
Yun-shuo Chen
Lei Shi
Yang Shen
Li-li Yang
Qing Yang
Molecular Biomedicine, 6 (1):
[30] Expression of indoleamine 2,3-dioxygenase in acute leukemic cells and the clinical significance
Chen, Xiang-Li
Guo, Jian-Min
Zhang, Yin
Niu, Xiao-Na
Pei, Xiao-Hang
Zhang, Wen-Hui
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8605 - 8609

← 1 2 3 4 5 →